# AxoGen Corporation – FDA Inspection, Mar 13, 2015

Source: https://www.keypedia.com/records/fda_inspections/axogen-corporation/5df42445-5b59-4ca8-8417-4e29551a6bc5
Source feed: FDA_Inspections

> FDA inspection 919999 of AxoGen Corporation, March 13, 2015. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 919999
- Company Name: AxoGen Corporation
- Inspection Date: 2015-03-13
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1315568 - 2026-04-09
- FDA Inspection 1180500 - 2022-09-22
- FDA Inspection 990232 - 2016-10-28
- FDA Inspection 823344 - 2013-03-14

Company: https://www.keypedia.com/companies/axogen-corporation/66fee473-9012-4a34-be96-52430f5ca334

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d